5 February 2026
- Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches are out of stock until late-February 2026
- Oxybutynin 5mg and 10mg modified-release tablets remain available and can support increased demand
- Oxybutynin 2.5mg/5ml and 5mg/5ml oral solution sugar free remains available and can support increased demand
- Oxybutynin 2.5mg and 5mg tablets remain available but cannot support increased demand
- Alternative anticholinergic/non-anticholinergic agents for urinary incontinence remain available and can support increased demand (see supporting information).
Find out more in the Medicine Supply Notification (PDF).